The use of contrast media in deceased kidney donors does not affect initial graft function or graft survival

Kidney International

Volumn 70, Issue 6, 2006, Pages 1149-1154

  Vigneau, C ^a,b   Fulgencio, J P ^a   Godier, A ^a   Chalem, Y ^c   El Metaoua, S ^a   Rondeau, E ^a   Tuppin, P ^c   Bonnet, F ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Agence de la Biomedecine   (France)

Author keywords

Diabetes mellitus; Iodinated contrast media injection; Organ donor; Renal transplant survival

Indexed keywords

CONTRAST MEDIUM; CREATININE; IODINATED CONTRAST MEDIUM;

ADOLESCENT; ADULT; ARTICLE; BRAIN DEATH; CADAVER KIDNEY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; INFANT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; URINE VOLUME;

AGE DISTRIBUTION; CADAVER; CONTRAST MEDIA; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33748431498     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001727     Document Type: Article

References (40)

1. Ojo AO, Leichtman AB, Punch JD et al. Impact of pre-existing donor hypertension and diabetes mellitus on deceased renal transplant outcomes. Am J Kidney Dis 2000; 36: 153-159.
2. Busson M, Benoit G, N'Doye P et al. Analysis of cadaver donor criteria on the kidney transplant survival rate in 5,129 transplantations. J Urol 1995; 154: 356-360.
3. Pokorná E, Vitko S, Chadimova M et al. Do the factors of the renal graft donor have an effect on early graft function and long term graft survival? Transpl Proc 1997; 29: 3278-3280.
4. Bertoni E, Zanazzi M, Rosati A et al. Causes and effects of delayed graft function in deceased renal transplantation: a multivariate analysis. Transplant Proc 1997; 29: 2799-2800.
5. Bresnahan BA, Johnson CP, McIntosh MJ et al. A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor. Am J Transplant 2002; 2: 366-372.
6. Basar H, Soran A, Shapiro R et al. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation 1999; 67: 1191-1193.
7. Becker YT, Leverson GE, D'Alessandro AM et al. Diabetic kidneys can safely expand the donor pool. Transplantation 2002; 74: 141-145.
8. Kasiske BL, Snyder JJ, Gilbertson D. Inadequate donor size in cadaver kidney transplantation. J Am Soc Nephrol 2002; 13: 2152-2159.
9. Odland MD, Kasiske BL. Kidneys from female donors are at increased risk for chronic allograft rejection. Transplant Proc 1993; 25: 912.
10. Vereerstraeten P, Wissing M, De Pauw L et al. Male recipients of kidneys from female donors are at increased risk of graft loss from both rejection and technical failure. Clin Transplant 1999; 13: 181-186.
11. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377-1381.
12. Alexander JW, Bennett LE, Breen TJ. Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry. Transplantation 1994; 57: 871-876.
13. Hariharan S, McBride MA, Bennett LE et al. Risk factors for renal allograft survival from older cadaver donors. Transplantation 1997; 64: 1748-1754.
14. Pessione F, Cohen S, Durand D et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2003; 75: 361-367.
15. Wood K, Becker B, McCartney J et al. Care of the potential donor. N Engl J Med 2004; 351: 2730-2739.
16. Perico N, Cattaneo D, Sayegh M et al. Delayed graft function in kidney transplantation. Lancet 2004; 362: 1814-1827.
17. Louvier N, Combes JC, Nicolas F et al. Cerebral angiography must have medicolegal value for brain death confirmation in France. Transplant Proc 1996; 28: 377.
18. Wijdicks EFM. The diagnosis of brain death. N Engl J Med 2001; 344: 1215-1221.
19. Dupas B, Gayet-Delacroix M, Villers D et al. Diagnosis of brain death using two-phase spiral CT. Am J Neuroradiol 1998; 19: 641-647.
20. Munari M, Zucchetta P, Carollo C et al. Confirmatory tests in the diagnosis of brain death: comparison between SPECT and contrast angiography. Crit Care Med 2005; 33: 2068-2073.
21. Manske CL, Sprafka JM, Strony JT et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-620.
22. Schultz SG, Lavelle KJ, Swain R. Nephrotoxicity of radiocontrast media in ischemic renal failure in rabbits. Nephron 1982; 32: 113-117.
23. Deray G, Bagnis C, Jacquiaud C et al. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney. Invest Radiol 1999; 34: 1-4.
24. Deray G, Baumelou B, Martinez F et al. Renal vasoconstriction after low and high osmolar contrast agents in ischemic and non ischemic canine kidney. Clin Nephrol 1991; 36: 93-96.
25. Galtung HK, Loken M, Sakariassen KS. Effect of radiologic contrast media on cell volume regulation in rabbit proximal renal tubules. Acad Radiol 2001; 8: 398-404.
26. Hietala SO, Segerstedt B, Wirell S et al. Effects of contrast media on renal graft function and survival after cerebral angiography of deceased donors. Acta Radiol 1989; 30: 317-319.
27. Weibull H, Cederholm C, Almen T et al. Does cerebral angiography of deceased kidney donors interfere with graft function? Acta Radiol 1987; 28: 451-455.
28. Karcioglu O, Ayrik C, Erbil B. The brain-dead patient or a flower in the vase? The emergency department approach to the preservation of the organ donor. Eur J Emerg Med 2003; 10: 52-57.
29. Guesde R, Barrou B, Leblanc I et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998; 352: 1178-1181.
30. Cittanova ML, Leblanc I, Legendre C et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-1622.
31. Droupy S, Blanchet P, Eschwege P et al. Long-term results of renal transplantation using kidneys harvested from non-heartbeating donors: a 15-year experience. J Urol 2003; 169: 28-31.
32. Marshall R, Ahsan N, Dhillon S et al. Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function. Surgery 1996; 120: 663-665.
33. Pfaff WW, Howard RJ, Patton PR et al. Delayed graft function after renal transplantation. Transplantation 1998; 65: 219-223.
34. Carmellini M, Di Stefano R, Filipponi F et al. Delayed graft function adversely affects one-year graft survival of deceased renal transplants. Transplant Proc 1996; 28: 359-360.
35. Boom H, Mallat MJ, De Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859-866.
36. Tepel M, van der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-184.
37. Tepel M. Acetylcysteine for the prevention of radiocontrast-induced nephropathy. Minerva Cardioangiol 2003; 51: 525-530.
38. Salom MG, Ramirez P, Carbonell LF et al. Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion. Transplantation 1998; 65: 1315-1321.
39. Thies JC, Teklote J, Clauer U et al. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transplant Int 1998; 11(Suppl 1): S390-S392.
40. DiMari J, Megyesi J, Udvarhelyi N et al. N-Acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272: F292-F298.